These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15304503)

  • 1. Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism.
    Beher D; Clarke EE; Wrigley JD; Martin AC; Nadin A; Churcher I; Shearman MS
    J Biol Chem; 2004 Oct; 279(42):43419-26. PubMed ID: 15304503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation.
    Takahashi Y; Hayashi I; Tominari Y; Rikimaru K; Morohashi Y; Kan T; Natsugari H; Fukuyama T; Tomita T; Iwatsubo T
    J Biol Chem; 2003 May; 278(20):18664-70. PubMed ID: 12637581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of gamma-secretase cleavage activation: is gamma-secretase regulated through autoinhibition involving the presenilin-1 exon 9 loop?
    Knappenberger KS; Tian G; Ye X; Sobotka-Briner C; Ghanekar SV; Greenberg BD; Scott CW
    Biochemistry; 2004 May; 43(20):6208-18. PubMed ID: 15147205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra- or intercomplex binding to the gamma-secretase enzyme. A model to differentiate inhibitor classes.
    Clarke EE; Churcher I; Ellis S; Wrigley JD; Lewis HD; Harrison T; Shearman MS; Beher D
    J Biol Chem; 2006 Oct; 281(42):31279-89. PubMed ID: 16899457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An NSAID-like compound, FT-9, preferentially inhibits gamma-secretase cleavage of the amyloid precursor protein compared to its effect on amyloid precursor-like protein 1.
    Sala Frigerio C; Kukar TL; Fauq A; Engel PC; Golde TE; Walsh DM
    Biochemistry; 2009 Nov; 48(46):10894-904. PubMed ID: 19821615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ production.
    Wanngren J; Ottervald J; Parpal S; Portelius E; Strömberg K; Borgegård T; Klintenberg R; Juréus A; Blomqvist J; Blennow K; Zetterberg H; Lundkvist J; Rosqvist S; Karlström H
    J Biol Chem; 2012 Sep; 287(39):32640-50. PubMed ID: 22851182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo.
    Eriksen JL; Sagi SA; Smith TE; Weggen S; Das P; McLendon DC; Ozols VV; Jessing KW; Zavitz KH; Koo EH; Golde TE
    J Clin Invest; 2003 Aug; 112(3):440-9. PubMed ID: 12897211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity.
    Weggen S; Eriksen JL; Sagi SA; Pietrzik CU; Ozols V; Fauq A; Golde TE; Koo EH
    J Biol Chem; 2003 Aug; 278(34):31831-7. PubMed ID: 12805356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain.
    Weggen S; Eriksen JL; Sagi SA; Pietrzik CU; Golde TE; Koo EH
    J Biol Chem; 2003 Aug; 278(33):30748-54. PubMed ID: 12777371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The same gamma-secretase accounts for the multiple intramembrane cleavages of APP.
    Zhao G; Tan J; Mao G; Cui MZ; Xu X
    J Neurochem; 2007 Mar; 100(5):1234-46. PubMed ID: 17241131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sulindac sulfide on the membrane architecture and the activity of gamma-secretase.
    Gamerdinger M; Clement AB; Behl C
    Neuropharmacology; 2008 May; 54(6):998-1005. PubMed ID: 18359496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.
    Iben LG; Olson RE; Balanda LA; Jayachandra S; Robertson BJ; Hay V; Corradi J; Prasad CV; Zaczek R; Albright CF; Toyn JH
    J Biol Chem; 2007 Dec; 282(51):36829-36. PubMed ID: 17932033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations.
    Czirr E; Leuchtenberger S; Dorner-Ciossek C; Schneider A; Jucker M; Koo EH; Pietrzik CU; Baumann K; Weggen S
    J Biol Chem; 2007 Aug; 282(34):24504-13. PubMed ID: 17573346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-secretase cleavage at amino acid residue 34 in the amyloid beta peptide is dependent upon gamma-secretase activity.
    Shi XP; Tugusheva K; Bruce JE; Lucka A; Wu GX; Chen-Dodson E; Price E; Li Y; Xu M; Huang Q; Sardana MK; Hazuda DJ
    J Biol Chem; 2003 Jun; 278(23):21286-94. PubMed ID: 12665519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective modulation of Abeta42 production in Alzheimer's disease: non-steroidal anti-inflammatory drugs and beyond.
    Leuchtenberger S; Beher D; Weggen S
    Curr Pharm Des; 2006; 12(33):4337-55. PubMed ID: 17105431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gamma-Secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid beta peptides of varying length.
    Murphy MP; Hickman LJ; Eckman CB; Uljon SN; Wang R; Golde TE
    J Biol Chem; 1999 Apr; 274(17):11914-23. PubMed ID: 10207012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
    Weggen S; Eriksen JL; Das P; Sagi SA; Wang R; Pietrzik CU; Findlay KA; Smith TE; Murphy MP; Bulter T; Kang DE; Marquez-Sterling N; Golde TE; Koo EH
    Nature; 2001 Nov; 414(6860):212-6. PubMed ID: 11700559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved residues within the putative active site of gamma-secretase differentially influence enzyme activity and inhibitor binding.
    Wrigley JD; Nunn EJ; Nyabi O; Clarke EE; Hunt P; Nadin A; De Strooper B; Shearman MS; Beher D
    J Neurochem; 2004 Sep; 90(6):1312-20. PubMed ID: 15341515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate sequence influences γ-secretase modulator activity, role of the transmembrane domain of the amyloid precursor protein.
    Sagi SA; Lessard CB; Winden KD; Maruyama H; Koo JC; Weggen S; Kukar TL; Golde TE; Koo EH
    J Biol Chem; 2011 Nov; 286(46):39794-803. PubMed ID: 21868380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of specific amyloid-beta(1-42) suppression by nonsteroidal anti-inflammatory drugs in young, plaque-free Tg2576 mice and in guinea pig neuronal cultures.
    Lanz TA; Fici GJ; Merchant KM
    J Pharmacol Exp Ther; 2005 Jan; 312(1):399-406. PubMed ID: 15340006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.